200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 144625-67-2

144625-67-2

144625-67-2 | 1H-Indole-3-carboxylic acid, 5-fluoro-2-methoxy-, [1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl ester

CAS No: 144625-67-2 Catalog No: AG001JVP MDL No:

Product Description

Catalog Number:
AG001JVP
Chemical Name:
1H-Indole-3-carboxylic acid, 5-fluoro-2-methoxy-, [1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl ester
CAS Number:
144625-67-2
Molecular Formula:
C19H26FN3O5S
Molecular Weight:
427.4902
IUPAC Name:
[1-[2-(methanesulfonamido)ethyl]piperidin-4-yl]methyl 5-fluoro-2-methoxy-1H-indole-3-carboxylate
InChI:
InChI=1S/C19H26FN3O5S/c1-27-18-17(15-11-14(20)3-4-16(15)22-18)19(24)28-12-13-5-8-23(9-6-13)10-7-21-29(2,25)26/h3-4,11,13,21-22H,5-10,12H2,1-2H3
InChI Key:
SSPCCAYAIDNNJX-UHFFFAOYSA-N
SMILES:
COc1[nH]c2c(c1C(=O)OCC1CCN(CC1)CCNS(=O)(=O)C)cc(cc2)F

Properties

Complexity:
651  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
427.158g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
427.491g/mol
Monoisotopic Mass:
427.158g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
109A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.2  

Literature

Title Journal
Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors. Pharmacological research 20120901
Upregulation of mucosal 5-HT3 receptors is involved in restoration of colonic transit after pelvic nerve transection. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20120501
Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice. Behavioural brain research 20120421
Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae. Life sciences 20120409
Effect of chronic pain on morphine-induced respiratory depression in mice. Neuroscience 20110203
A 5-HT(4)-receptor activation-induced neural plasticity enhances in vivo reconstructs of enteric nerve circuit insult. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100701
5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes. Journal of molecular and cellular cardiology 20100101
Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines. Bioorganic & medicinal chemistry 20090315
Endogenous ghrelin and 5-HT regulate interdigestive gastrointestinal contractions in conscious rats. American journal of physiology. Gastrointestinal and liver physiology 20080801
Contribution of active and inactive states of the human 5-HT4d receptor to the functional activities of 5-HT4-receptor agonists. Journal of pharmacological sciences 20080701
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes. American journal of physiology. Heart and circulatory physiology 20071001
5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice. British journal of pharmacology 20070401
Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon. Life sciences 20070306
A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs. American journal of physiology. Gastrointestinal and liver physiology 20050801
Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes. Journal of molecular and cellular cardiology 20050801
Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants. Naunyn-Schmiedeberg's archives of pharmacology 20050601
Molecular characterization of a purified 5-HT4 receptor: a structural basis for drug efficacy. The Journal of biological chemistry 20050527
Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists. Biological psychiatry 20050415
Electrophysiological effects of prucalopride, a novel enterokinetic agent, on isolated atrial myocytes from patients treated with beta-adrenoceptor antagonists. The Journal of pharmacology and experimental therapeutics 20050401
Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure. Cardiovascular research 20050301
Effects of the selective serotonin reuptake inhibitor, fluoxetine, on regional gastric contractility. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20050201
New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket. British journal of pharmacology 20041001
Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex. The Journal of physiology 20040501
Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease. Neuroscience 20040101
A 5-HT4 agonist mosapride enhances rectorectal and rectoanal reflexes in guinea pigs. American journal of physiology. Gastrointestinal and liver physiology 20030801
[3H]GR113808 binding to serotonin 5-HT(4) receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological study. Journal of neural transmission (Vienna, Austria : 1996) 20030701
5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030401
New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization. Journal of medicinal chemistry 20030102
5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphé nucleus 5-HT neuronal activity. The European journal of neuroscience 20020901
Modulation of 5-HT4 receptor function in the rat isolated ileum by fluoxetine: the involvement of endogenous 5-hydroxytryptamine. British journal of pharmacology 20020501
Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role. Pharmacology, biochemistry, and behavior 20020401
Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies. The Journal of clinical endocrinology and metabolism 20020301
Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins. Molecular pharmacology 20020101
Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors. Neuropharmacology 20011201
The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. The Journal of biological chemistry 20011130
Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle. British journal of pharmacology 20011101
Computational model of the complex between GR113808 and the 5-HT4 receptor guided by site-directed mutagenesis and the crystal structure of rhodopsin. Journal of computer-aided molecular design 20011101
Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20011001
Pharmacological characterization of a novel 5-HT4 receptor agonist, TS-951, in vitro. Pharmacology 20010701
The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. European journal of pharmacology 20010629
Effect of the intracerebroventricular administration of GR 113808, a selective 5-HT4 antagonist, on water intake during hyperosmolarity and hypovolemia. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010601
5-HT(4) receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study. British journal of pharmacology 20010401
Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. The European journal of neuroscience 20010301
5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle. Naunyn-Schmiedeberg's archives of pharmacology 20010201
Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus. Japanese journal of pharmacology 20010101
Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells. British journal of pharmacology 20001001
Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling. British journal of pharmacology 20000601
Effect of YNS-15P, a new alpha-2 adrenoceptor antagonist, on stress-stimulated colonic propulsion in rats. The Journal of pharmacology and experimental therapeutics 19981101
Cloning and expression of a human serotonin 5-HT4 receptor cDNA. Journal of neurochemistry 19971101
Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase. Neuroreport 19971020
Cloning, expression and pharmacology of the mouse 5-HT(4L) receptor. FEBS letters 19961125
[3H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor. European journal of pharmacology 19960523
5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. British journal of pharmacology 19950301

Related Products

© 2019 Angene International Limited. All rights Reserved.